Cargando…
Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study
PURPOSE: Beta blockers (BB) have been associated with improved, worsened, or unchanged breast cancer outcomes in previous studies. This study examines the association between the post-diagnostic use of BBs and death from breast cancer in a large, representative sample of New Zealand (NZ) women with...
Autores principales: | Scott, Oliver William, Tin Tin, Sandar, Elwood, J. Mark, Cavadino, Alana, Habel, Laurel A., Kuper-Hommel, Marion, Campbell, Ian, Lawrenson, Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993732/ https://www.ncbi.nlm.nih.gov/pubmed/35286523 http://dx.doi.org/10.1007/s10549-022-06528-0 |
Ejemplares similares
-
Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study
por: Scott, Oliver William, et al.
Publicado: (2023) -
Obesity and breast cancer outcomes in chemotherapy patients in New Zealand – a population-based cohort study
por: Elwood, J. Mark, et al.
Publicado: (2018) -
Use of Non-Cancer Medications in New Zealand Women at the Diagnosis of Primary Invasive Breast Cancer: Prevalence, Associated Factors and Effects on Survival
por: Aye, Phyu Sin, et al.
Publicado: (2020) -
Associated Factors and Survival Outcomes for Breast Conserving Surgery versus Mastectomy among New Zealand Women with Early-Stage Breast Cancer
por: Abrahimi, Mohammad Shoaib, et al.
Publicado: (2021) -
Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute?
por: Tin Tin, Sandar, et al.
Publicado: (2016)